Short answer
Universal Health Services (UHS) filed its fiscal 2024 10-K annual report with the SEC on Feb 26, 2025. It reported revenue of $15.8B (+10.8% year over year) and net income of $1.1B.
- Top risk flagged: Legal risk: Ongoing litigation Pavilion and Cumberland cases with $221M insurance coverage remaining, potential material adverse impact if coverage exhausted
FY2024 key financial metrics · XBRL
- Revenue
- $15.8B
- +10.8% YoY
- Net income
- $1.1B
- +59.1% YoY
- Operating margin
- 10.6%
- +2.4 pp YoY
- EPS (diluted)
- $16.82
- +64.4% YoY
- ROE
- 17.1%
- +5.5 pp YoY
- Operating cash flow
- $2.1B
- +63.0% YoY
Source: XBRL data from the Universal Health Services (UHS) FY2024 10-K on SEC EDGAR. USD.
Universal Health Services FY2024 10-K analysis
AI summary of each section, grounded in the filing text
Business Overview
- Core business model: Operates acute care hospitals and behavioral health facilities providing healthcare services across the U.S.
- No new products, services, or segments introduced or emphasized in this filing year
- Continued reliance on longstanding advisory and lease agreements with Universal Health Realty Income Trust detailed in updated exhibits
- No updated quantitative metrics disclosed in business section; filings focus on legal, governance and financial documentation updates
- Filing primarily updates incorporation by reference of Proxy Statement sections and multiple amendments to Credit Agreement and indentures through 2024
Management Discussion & Analysis
- Net revenues $1.58B from UK behavioral health facilities in 2024, up from $1.52B in 2023 (44% of consolidated revenues vs 43%)
- Acute care and outpatient segment revenue 56% of consolidated in 2024, down 1 point from 57% in 2023
- Total UK behavioral health assets $1.358B as of Dec 31, 2024 vs $1.327B in 2023
- No margins or profitability percentages disclosed in this section
- Forward-looking statements highlight regulatory, competitive, and healthcare industry risks impacting future performance
Risk Factors
- Legal risk: Ongoing litigation Pavilion and Cumberland cases with $221M insurance coverage remaining, potential material adverse impact if coverage exhausted
- Macroeconomic risk: Inflationary pressures on personnel costs and operating expenses could increase costs faster than reimbursement, risking capital resource depletion
- Supply chain risk: Proposed/new significant tariffs on imported pharmaceuticals and medical devices could escalate costs and disrupt supply chains
- Competitive risk: Increased hospital physician costs in ER and anesthesiology areas, with mitigation efforts only moderately effective, risking operating results
- Financial risk: Elevated borrowing costs from recent interest rate increases have significantly increased interest expense, reducing free cash flow
Generated from the filing text; verify against the original. How to read a 10-K
Other Universal Health Services annual reports
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.